Last reviewed · How we verify
NCT07066488
Brief ACT Intervention for Problem Gambling: A Pilot Study
NA trial testing Acceptance and Commitment Therapy (ACT) in Problem Gambling in 5 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | Universidad Europea de Madrid |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 1 October 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Acceptance and Commitment Therapy (ACT)
Conditions studied
- Problem Gambling — all drugs for Problem Gambling →
Sponsor
Universidad Europea de Madrid
Who can join
Adults 18 to 25, any sex, with Problem Gambling. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot study is to learn if Acceptance and Commitment Therapy (ACT) works to treat Problem Gambling in young adults.The main questions it aims to answer are: * Does ACT therapy improve health and gambling behavior? * Is an 8-week online group therapy format viable for youth with gambling problems? Researchers will assess whether changes in health, gambling behavior, and other psychological variables are observed after eight weeks of therapy. Participants will: * Attend weekly online group sessions for 8 weeks * Learn new tools that they will put into practice after the sessions * Be required to complete evaluation questionnaires before and after the intervention and at the 3- and 6-month follow-up
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07066488
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Acceptance and Commitment Therapy (ACT)
Trials testing the same drug.
- NCT06704061 — Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain · NA · recruiting
- NCT07175402 — Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction - Beta Trial · NA · completed
- NCT06887751 — Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction · NA · completed
- NCT07256093 — The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regu · NA · completed
- NCT06162624 — Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons · NA · recruiting
Other recruiting trials for Problem Gambling
Currently open trials in the same condition.
- NCT06561139 — Mindfulness as an add-on Intervention in Treatment for Problem Gambling in Clinical Settings in Sweden · NA · recruiting
Other Universidad Europea de Madrid trials
Trials by the same sponsor.
- NCT07506837 — Effects of an HABIT-ILE-Based Intervention in Children With Cerebral Palsy · NA · not yet recruiting
- NCT07470268 — Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Panc · NA · not yet recruiting
- NCT07494903 — Effects of Vibrational Therapy on Pelvic Floor Muscle Strength and Tone in Healthy Women · NA · not yet recruiting
- NCT07524010 — Multi-Omics Characterization of Percutaneous Electrolysis in Low Back Pain · Phase 1 · enrolling by invitation
- NCT07484776 — Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07066488 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Europea de Madrid
- Last refreshed: 15 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07066488.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing